This was the stock's third consecutive day of losses.

Zimmer Biomet Holdings, Inc. sees growth potential with Monogram acquisition enhancing robotics and Paragon 28 integration.

Zimmer Biomet Holdings Inc. closed 17.76% short of its 52-week high of $116.71, which the company reached on September 3rd.

The move is expected to bolster Zimmer’s ROSA Robotics platform with Monogram's semi-autonomous and fully autonomous robotic technologies.

--Zimmer Biomet Holdings, Inc., a global medical technology leader, and Monogram Technologies Inc., an orthopedic robotics company, today announced they have entered into a definitive agreement ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Zimmer Biomet and Monogram undertake no obligation to update any of these forward-looking statements as the result of new information or to reflect events or circumstances after the date of this ...

Upon closing of the proposed transaction, Zimmer Biomet expects to have a clear pathway to become the first and only company in orthopedics to offer a fully autonomous surgical robot.

Monogram Orthopaedics Inc ( ($MGRM) ) has issued an announcement. On July 28, 2025, Monogram Technologies Inc. provided its stockholders with FAQs ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported net sales of $1.909 million in Q1, reflecting a 1.1% increase on a reported basis and a 2.3% rise when excluding the effects of foreign currency. While ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) designs, manufactures, and markets orthopedic reconstructive products. It also offers ...